Philadelphia, Pennsylvania — According to state and local development sources, Adare Pharma Solutions plans to invest $16,800,000.00 to expand in Philadelphia. The company is creating 115 new jobs at this facility. The company plans to occupy the new space at 1100 Orthodox St in Philadelphia, on or about January 1, 2025. According to the company website Adare Pharma Solutions is a global technology-driven CDMO providing end-to-end integrated services, from product development through commercial manufacturing and packaging, with expertise focusing on oral dosage forms for the Pharmaceutical industry. Adares specialized technology platforms provide taste masking, controlled release, solubility enhancement, and patient-centric dosing solutions. With a proven history in drug delivery, Adare has developed and manufactures more than 45 products sold by customers worldwide.

To learn more about Adare Pharma Solutions, visit http://adarepharmasolutions.com/

Company Contact:
Tom Sellig, Chief Executive Officer
https://www.linkedin.com/in/tomsellig/
609-450-1312

SOURCE: http://www.intelligence360.io
Copyright (c) 2024 SI360 Inc. All rights reserved.